Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.

from NYT > Business Day https://ift.tt/2IpPvlz
via IFTTT